EC Pulmonology and Respiratory Medicine

Introduction: In Burkina Faso, hospital studies on smoking and smoking cessation are few and far between, despite the fact that smoking-affected patients with serious pathologies need treatment both for their pathologies and for smoking. The aim of the study was to screen for smoking and factors associated with smoking cessation in the pneumology, cardiology and neurology departments of the CHU-YO.

Methods: This was a descriptive and analytical cross-sectional study with prospective collection of outpatients and inpatients from March 27, 2023 to May 25, 2023 in these three departments of the CHU-YO. Data were analyzed using EPI INFO software version 7.2.5.0.

Results: A total of 2523 patients were interviewed and 198 of them were included, representing a hospital smoking prevalence of 7.2%. Among them, 20.3% were ex-smokers, 31.9% (48/) current smokers, and 47.8% former smokers. The average age of smoking initiation was 25 ± 11.2 years with ranges from 10 to 65 years and the average duration of smoking was 24.8 ± 16.6 years. Among current smokers, 57.9% had a moderate dependence on cigarettes according to the Fagerström score. The pathologies most encountered in these patients depending on the services were hypertension (27.3%), stroke (9.3%) and tuberculosis (5.6%). The Richmond motivation score showed that our patients had good motivation (37.9%) and they explained their desire to quit by the desire to be in good health. The factors associated with smoking cessation were other associated substances and hypertension.

Conclusion: This study shows that we need to continue and reinforce awareness-raising and multidisciplinary management.

Keywords: Screening; Tobacco; Dependence; Motivation; Smoking Cessation

1. Venetz J. “Le tabac, sa composition, son utilisation”. BCV 62 (1944): 108‑
2. “Tabac” (2022).
3. Le rôle des professionnels de la santé dans la lutte anti- tabac. Comment lutter contre l’épidemie de tabagisme. Guide OMS. JMST (2005).
4. Ministère de la santé. Rapport de la deuxième enquête nationale sur la prévalence des principaux facteurs de risque communs de maladies non transmissibles au Burkina Faso. Burkina Faso (2022): 229.
5. Lutte contre le tabac au Burkina Faso: Le Ministère de la Santé et l’OMS outillent les journalistes dans la lutte antitabac | OMS | Bureau régional pour l’Afrique (2022).
6. Balima JT. Inauguration d’un centre de sevrage à Ouagadougou  un espoir pour les fumeurs du Burkina Faso - Médiaterre (2022).
7. World Health Organization. WHO STEPS surveillance manual: the WHO STEPwise approach to chronic disease risk factor surveillance / Noncommunicable Diseases and Mental Health, World Health Organization (2005): 490 Pages.
8. Evaluation de la motivation Test de Richmond R et al (2023).
9. Test de Fagerstrom simplifié.pdf (2023).
10. J Hicham., et al. “Est-ce que le fumeur connaît les méfaits du tabac?” Journal of Functional Ventilation and Pulmonology 6 (2015): 1-53.
11. Ouédraogo G., et al. “Prévalence et facteurs associés au tabagisme chez les personnes infectées par le VIH au Burkina Faso”. Journal of Functional Ventilation and Pulmonology 28 (2018): 21‑28.
12. Janah H., et al. “La tuberculose pulmonaire et le tabac: à propos de 100 cas”. Pan African Medical Journal 19 (2014): 202.
13. Tavolacci MP., et al. “Prévalence et caractéristiques socio-sanitaires des fumeurs invétérés en Haute-Normandie”. info. SFSP Santé Publique 21.6 (2009): 583‑593.
14. Koffi N., et al. “Connaissances, attitudes et comportements des patients vis-à-vis du tabagisme en milieu africain à Abidjan (Côte d’Ivoire)”. Revue de Pneumologie Clinique 4 (2004): 217‑222.
15. Ouédraogo G., et al. “Caractéristiques des tabagiques reçus en consultation d’aide au sevrage tabagique au Centre Hospitalier Universitaire Yalgado Ouedraogo (Ouagadougou - Burkina Faso)”. Revue de Pneumologie Clinique 32 (2019): 32‑3
16. Rakover A., et al. “Consultations de tabacologie pendant le mois sans tabac: profil des fumeurs et sevrage”. Revue des Maladies Respiratoires5 (2021): 443‑454.
17. Mokhtar Hamdi Cherif. “Problématique du tabac en Afrique francophone et perspectives régionales de l’OTAF”. Global Health Promotion 4 (2005): 45‑47.
18. Radhouane F., et al. “Tabagisme en Tunisie: comportements et connaissances”. Bulletin of the World Health Organization 5 (2002): 350-356.
19. Maiga S., et al. “Caractéristiques du tabagisme des fumeurs de la ville de Ouahigouya - Burkina Faso”. Journal of Functional Ventilation and Pulmonology13 (2019): 1‑68.
20. Comité National du Recensement Institut National de la Statistique et de la Démographie. 5ème RGPH Cinquième Recensement Général de la Population et de l’Habitation du Burkina Faso (2022).
21. Ouédraogo A., et al. “Le tabagisme parmi les personnels de santé d’un hôpital au Burkina Faso” (2024).
22. Le Faou AL and Scemama O. “Faisabilité d’un dépistage systématique des comportements addictifs chez les patients hospitalisés”. SFSP Santé Publique 18 (2006): 7-21.
23. Ferguson JA., et al. “Predictors of 6-month tobacco abstinence among 1224 cigarettesmokers treated for nicotine dependence”. Addictive Behaviors 7 (2003): 1203-1218.
24. Martinet Y., et al. “Le contrôle du tabac”. Journal of Functional Ventilation and Pulmonology 3 (2011): 1-78.
25. R Doll., et al. “Mortality in relation to smoking: 50 years’ observations on male”. British Medical Journal7455 (2004): 1519.